Professors

 

Assoz.- Prof. Mag. Dr. Anna Weinzinger, Privatdoz.

room: 2D178

tel: +43 1 4277 55311

e-mail: anna.stary@univie.ac.at

Research: Molecular modeling of ion channels

Teaching: more information

Anna Weinzinger (photo: Michael Bründl)

 Publications

Zeige Ergebnisse 41 - 60 von 70
Lukacs P, Gawali V, Cervenka R, Ke S, Rubi L, Zarrabi T et al. Exploring the structure of the voltage-gated Na+ channel by an engineered drug access pathway to the receptor site for local anesthetics. Journal of Biological Chemistry. 2014;289(31):21770-21781. doi: 10.1074/jbc.M113.541763

Saxena P, Linder T, Weinzinger A, Timin E, Ecker GF, Hering S. Refined Molecular Model for Dofetilide-Herg Channel interaction. Indian Journal of Pharmacology. 2013 Dez;45:S32-S32.

van der Heyden MAG, Stary-Weinzinger A, Sanchez-Chapula JA. Inhibition of cardiac inward rectifier currents by cationic amphiphilic drugs. Current molecular medicine. 2013 Sep;13(8):1284-98.

Takanari H, Nalos L, Stary-Weinzinger A, de Git KCG, Varkevisser R, Linder T et al. Efficient and specific cardiac IK₁ inhibition by a new pentamidine analogue. Cardiovascular Research. 2013 Jul 1;99(1):203-214. doi: 10.1093/cvr/cvt103

Varkevisser R, Houtman MJC, Linder T, de Git KCG, Beekman HDM, Tidwell RR et al. Structure-activity relationships of pentamidine-affected ion channel trafficking and dofetilide mediated rescue. British Journal of Pharmacology. 2013 Jul;169(6):1322-1334. doi: 10.1111/bph.12208

Garg V, Stary-Weinzinger A, Sanguinetti MC. ICA-105574 interacts with a common binding site to elicit opposite effects on inactivation gating of EAG and ERG potassium channels. Molecular Pharmacology. 2013 Apr;83(4):805-813. doi: 10.1124/mol.112.084384

Saxena P, Erker T, Bauer F, Weinzinger A, Linder T, Hering S et al. Drug Trapping in hERG Channels does not Require Closure of the Activation Gate. Biophysical Journal. 2013 Jan 29;104(2):266A-266A.

Linder T, de Groot BL, Stary-Weinzinger A. Probing the energy landscape of activation gating of the bacterial potassium channel KcsA. PLoS Computational Biology. 2013;9(5):e1003058. doi: 10.1371/journal.pcbi.1003058

Beyl S, Depil K, Hohaus A, Weinzinger A, Linder T, Timin E et al. Neutralisation of a single voltage sensor affects gating determinants in all four pore-forming S6 segments of Ca(V)1.2: a cooperative gating model. Pflügers Archiv: European Journal of Physiology. 2012 Okt;464(4):391-401. doi: 10.1007/s00424-012-1144-5

Ke S, Zangerl EM, Weinzinger A. Distinct interactions of Na(+) and Ca(2+) ions with the selectivity filter of the bacterial sodium channel Na(V)Ab. Biochemical and Biophysical Research Communications. 2012;430(4):1272-1276. doi: 10.1016/j.bbrc.2012.12.055

Jansen SA, Kleerekooper I, Hofman ZLM, Kappen IFPM, Weinzinger A, van der Heyden MAG. Grayanotoxin Poisoning: 'Mad Honey Disease' and Beyond. Cardiovascular Toxicology. 2012;12(3):208-215. doi: 10.1007/s12012-012-9162-2

Phillips S, Brammer AE, Rodriguez L, Lim HH, Weinzinger A, Matulef K. Surprises from an Unusual CLC Homolog. Biophysical Journal. 2012;103(9):44-46. doi: 10.1016/j.bpj.2012.08.063

Boukharta L, Keranen H, Weinzinger A, Wallin G, De Groot B, Aqvist J. Computer simulations of structure-activity relationships for HERG channel blockers. Biochemistry. 2011;50(27):6146-6156. doi: 10.1021/bi200173n

Garg V, Weinzinger A, Sachse F, Sanguinetti MC. Molecular Determinants for Activation of Human Ether-a-go-go-related Gene 1 Potassium Channels by 3-Nitro-N-(4-phenoxyphenyl) Benzamide. Molecular Pharmacology. 2011;80(4):630-637. doi: 10.1124/mol.111.073809

Beyl S, Depil K, Hohaus A, Weinzinger A, Timin E, Shabbir W et al. Physicochemical properties of pore residues predict activation gating of Ca(V)1.2: A correlation mutation analysis. Pflügers Archiv: European Journal of Physiology. 2011;461(1):53-63. doi: 10.1007/s00424-010-0885-2

Depil K, Beyl S, Weinzinger A, Hohaus A, Timin E, Hering S. Timothy mutation disrupts the link between activation and inactivation in Ca(V)1.2 protein. Journal of Biological Chemistry. 2011;286(36):31557-31564. doi: 10.1074/jbc.M111.255273

Karmazinova M, Beyl S, Weinzinger A, Suwattanasophon C, Klugbauer N, Hering S et al. Cysteines in the loop between IS5 and the pore helix of Ca(V)3.1 are essential for channel gating: Cysteines in the loop between IS5 and the pore helix of Ca(V)3.1 are essential for channel gating. Pflügers Archiv: European Journal of Physiology. 2010;460(6):1015-1028. doi: 10.1007/s00424-010-0874-5

de Boer T, Nalos L, Weinzinger A, Kok B, Houtman MJC, Antoons G et al. The anti-protozoal drug pentamidine blocks KIR2.x-mediated inward rectifier current by entering the cytoplasmic pore region of the channel. British Journal of Pharmacology. 2010;159(7):1532-1541. doi: 10.1111/j.1476-5381.2010.00658.x

Zeige Ergebnisse 41 - 60 von 70

 Projects

Zeige Ergebnisse 1 - 7 von 7

Novel approaches to investigate the regulation of G-protein coupled inward rectifier K+ channels by Gβγ

Weinzinger, A. (Projektleiter*in) & Friesacher, T. (Co-Projektleiter*in)

1/08/2131/07/24

Projekt: Forschungsförderung


PROSTAGLANDINES - POTENTIAL THERAPEUTICS FOR DEND SYNDROME?

Weinzinger, A. (Projektleiter*in)

1/12/2030/07/23

Projekt: Forschungsförderung


Sulfonylharnstoffe

Weinzinger, A. (Projektleiter*in)

1/03/1528/02/19

Projekt: Forschungsförderung


hERG K+ Channel activators

Weinzinger, A. (Projektleiter*in)

4/11/144/11/15

Projekt: Forschungsförderung


hEAG1 channel blockers

Weinzinger, A. (Projektleiter*in)

15/03/1414/03/15

Projekt: Forschungsförderung


Molekulare Arzneistoff-Targets

Hering, S. (Projektleiter*in), Ecker, G. (Co-Projektleiter*in), Maulide, N. (Co-Projektleiter*in), Weinzinger, A. (Co-Projektleiter*in) & Gonzalez Herrero, L. (Co-Projektleiter*in)

1/12/1031/12/22

Projekt: Forschungsförderung


hERG potassium channel

Weinzinger, A. (Projektleiter*in)

27/10/1031/12/11

Projekt: Forschungsförderung


Zeige Ergebnisse 1 - 7 von 7